Search

everythinglearnresearchcommunity

for

Search:↓

Nanoparticles improve drug delivery through the skin but more research is needed on their long-term effects and skin penetration challenges.

Congenital Adrenal Hyperplasia is a genetic disorder with two forms, causing symptoms like early puberty and severe acne, but can be identified through screening and treated with glucocorticoids.

Nanoparticles can improve skin drug delivery but have challenges like toxicity and stability that need more research.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

Nanoparticles can improve skin treatments by better targeting hair follicles, but more research is needed for advancement.

New hormonal contraceptives are safer, have fewer side effects, and offer health benefits for women.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Oral minoxidil promotes hair growth but may cause side effects; needs monitoring.

The new micelle formulation delivers acne treatment more effectively and safely than current gels.

Squalene-based carriers improve delivery of a treatment to hair follicles for alopecia areata.

Oral isotretinoin may slightly improve acne but increases the risk of side effects like dry lips and skin; more research is needed to understand its full risks and benefits.

Androgens play a complex role in skin conditions like acne and hair loss in women, and normal blood levels don't always show true androgen status.

Androgens like testosterone affect hair growth and oil production differently across body parts and individuals.

Pregnant women often experience skin and hair changes, with over half getting stretch marks and pigment changes, and should be cautious with cosmetic procedures due to potential risks.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

Vitamins A, B3, C, D, and E can improve skin health and immunity.

Oral contraceptives can cause skin issues like dark patches, acne, yeast infections, sensitivity to light, spider veins, skin rashes, and hair loss.

Low-dose oral minoxidil safely treats hair loss, with hypertrichosis as main side effect.

Ketoconazole cream is effective for skin conditions like seborrheic dermatitis and may help with hair loss and other skin issues, with generally mild side effects.

Finasteride affects urinary steroid profiles and can potentially hide steroid abuse in sports drug testing.

Using anabolic-androgenic steroids can cause skin problems like acne and hair loss in athletes.

Certain 4-azasteroids are effective at blocking the enzyme that processes testosterone in human skin and could help treat acne, excessive hair growth, and male pattern baldness.

Eating disorders can cause skin problems that need treating the underlying condition for better health.

Single Blimp1+ cells can create functional sebaceous gland organoids in the lab.

PRP therapy may improve skin and hair conditions, but more research with standard methods is needed.

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

The conclusion is that better understanding and more research are needed to effectively manage follicular and scarring disorders in skin of color, with an emphasis on patient education and cultural awareness.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

Nanocarriers can make acne treatments more effective and gentle on the skin.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.